KEGG   DRUG: Bexatamig
Entry
D13057                      Drug                                   
Name
Bexatamig (USAN/INN)
Formula
C6538H10091N1737O2049S48
Exact mass
147257.5414
Mol weight
147348.70
Sequence
(A chain)
EVQLVQSGAE VKKPGESLKI SCKGSGYSFT DYYMKWARQM PGKGLEWMGD IIPSSGATFY
NQKFKGQVTI SADKSISTTY LQWSSLKASD TAMYYCARSH LLRASWFAYW GQGTMVTVSS
ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKRVEP KSCDKTHTCP PCPAPELLGG
PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
QQGNVFSCSV MHEALHNHYT QKSLSLSPGS TGSQVQLVQS GAEVKKPGSS VKVSCKASGY
TFSDYVINWV RQAPGQGLEW MGEIYPGSGT NYYNEKFKAK ATITADKSTS TAYMELSSLR
SEDTAVYYCA RRGRYGLYAM DYWGQGTTVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC
LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS VVTVPSSSLG TQTYICNVNH
KPSNTKVDKR VEPKSCDKTH S
(B chain)
DIVMTQSPDS LAVSLGERAT INCESSQSLL SSGNQKNYLT WYQQKPGQPP KPLIYWASTR
ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCQNDYSY PYTFGQGTKL EIKRTVAAPS
VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC DKTHTCPPCP APELLGGPSV
FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSREEMTK
NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
NVFSCSVMHE ALHNHYTQKS LSLSPGK
(C chain)
DIQMTQSPSS LSASVGDRVT ITCRASQDIS NYLNWYQQKP GKAPKLLIYY TSRLHSGVPS
RFSGSGSGTD FTFTISSLQP EDIATYFCQQ GNTRPWTFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: A22-A96, A147-A203, A223-B220, A229-B226, A232-B229, A264-A324, A370-A428, A475-A549, A600-A656, A676-C214, B23-B94, B140-B200, B261-B321, B367-B425, C23-C88, C134-C194)
  Type
Peptide
Efficacy
Antineoplastic
  Type
Bispecific antibody
Target
IL3RA (CD123) [HSA:3563] [KO:K04737]
NCR1 (CD335) [HSA:9437] [KO:K06741]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04151  PI3K-Akt signaling pathway
hsa04630  JAK-STAT signaling pathway
hsa04650  Natural killer cell mediated cytotoxicity
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Interleukin receptors
    IL3RA (CD123)
     D13057  Bexatamig (USAN/INN)
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    NCR1 (CD335)
     D13057  Bexatamig (USAN/INN)
Other DBs
CAS: 2871775-98-1
PubChem: 505917330
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system